Crop biotech industry fears ‘mistrust of science’ stifling farming innovation in Europe

| | April 5, 2019
GM crops europe x
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

For several weeks last fall I spent much of my time traveling across Europe, visiting with many of the representatives from the major players in the world’s crop protection/seed business.

It was very refreshing to discover what many of these companies are up to now that the wave of industry consolidation that began in 2016 is finally subsiding. It was also great to hear from these global entities regarding their business plans for agriculture globally in such far-reaching places as Asia, the Middle East, the Pacific Region, and the Americas.

[Editor’s note: Eric Sfiligoj is the Editor of CropLife Magazine]

And then there’s Europe.

Related article:  Viewpoint: When it comes to CRISPR crop regulations, Europe must trust its biotech experts

Considering that all of these companies are based in Europe, it was a little odd to not hear much about market plans for this continent. But I quickly realized why once I heard more from the company representatives.

“I’m very concerned for future innovation for agriculture in Europe,” BASF’s Markus Heldt said. “In Europe there’s a clear mistrust of science, and it’s not improving.”

Read full, original article: Agriculture’s European Front

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend